Design Pharmaceuticals
Focus: Design Pharmaceuticals is a Cambridge-based specialty pharma company focused on small molecule drug design with a primary presence in neurology. The company operates a portfolio of generic and branded products with significant revenue concentration in ophthalmology and dermatology.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Design Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Design Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthWatch
Pipeline
Early-stage
50 total
LOE Risk
1 imminent
CLINDESSE
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$16M Part DStable
Post-LOE
Flagship product representing 38% of company revenue; carbonic anhydrase inhibitor in mature market.
Help build intelligence for Design Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.